DIABETES MANAGEMENT

Diabetes Management

Diabetes Management

Introduction

Diabetes is one of the most significant health threats of the 21st century. It is a leading cause of disability and mortality, and its prevalence has increased to the point that it has been termed an epidemic. Like many other diseases as may occur during aging, diabetes is a common disease common to the elderly and is a slowly progressive cause of increased morbidity and mortality. Especially common among the elderly, Diabetes is characterized in its evolution by the insidious onset of numerous complications (Nissen, 2005, 7). In this population, the disorder of blood sugar regulation complements and complicates the polypathology who singled demonstrating, once again, the principle of comprehensive care. Renal function, visual acuity, cardiac status and the occurrence of a neurological device are challenges imposed by diabetes patients and caregivers. The disease symptoms require primary care. Care for an elderly patient with diabetes is a dynamic and evolving process based on a comprehensive initial assessment, identification of complications and the establishment of a program on the proposed treatments and rhythm monitoring.

Faced with numerous complications that characterize its evaluation, a comprehensive assessment must be carried out upon discovery in order to consider the best care the most appropriate, whether dealing with lifestyle or drug therapies. The presence or absence of Co morbidities are particularly frequent in geriatrics, such as cognitive disorders, protein-energy malnutrition, heart failure or kidney warrants to be evaluated and explored before considering the modalities of treatment (Bantle, 2006, 89). It is the same on the lifestyle of the patient. The decision of the choice of therapy will be unique to each, taking into account information of medico-psycho-social factors. The aim of this research is to develop an in-depth understanding of the diabetes management, emerging adults with diabetes face unique challenges in managing a complex disease process while carrying out the exploration, experimentation, and risk taking normative in this developmental period (Lai, 2007, 454).

How is it diagnosed?

Random blood glucose, venous plasma, greater than 200 mg / dl.

A fasting plasma glucose greater than or equal to 126 mg / dl, in 2 doses on different days.

Plasma glucose at 2 hours to perform the test Oral Glucose Tolerance = 200 mg / dl.

Symptoms

Increased hunger and thirst, with dry mouth

Excessive sleepiness, which is noticeable and that are especially after meals

Blurred vision

Bacterial infections or fungus most frequently (urinary infections, vaginitis, etc)

When that person feels symptoms of unexplained injuries and illnesses and visits to a specialist and determines the presence of diabetes, it may be too late, that inside may be late in the disease.

The pathology and dosages of insulin in the blood and the pancreas of diabetics indicate that the production conditions of this disease are different from those that cause experimental talmente (Hillson, 2002, 115). In this case, it is necessary to remove or destroy all the islets to induce diabetes, whereas in human diabetes well there is never destruction of the islets and in the generation its of cases, there is only a partial alteration or reduction ...